Across TCGA pan-cancer cohorts, LINC00900 RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated LINC00900 data layer.
The strongest signal is observed in uveal melanoma (UVM), where higher LINC00900 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC00900 expression acts as an unfavorable survival marker, although some lineages such as THCA and LUAD show a favorable association.
UVM, THCA, and LUAD are the cancer types where LINC00900 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.